Data News > Top gainers in Biotechnology and Gene Therapy - WAT, LLY, GILD, A
WAT is trading UP for the last 1 days, and it at trading at $380.97 with volume of 474,570 and a one day change of $6.77 (1.81%). Waters Corporation has a 52-week low of 279.31 and a 52-week high of $397.02. The business's 50-day moving average price is $364.31 and its 200 day moving average price is $332.96. The firm has a market cap of $22 million, a P/E ratio of 38.99, and a beta of 0.97.
MILFORD, Mass. , Jan. 10, 2025 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announced that it will host an Investor Day on Wednesday, March 5th, 2025, in New York City, starting at 8:30 AM ET.
For more information on WAT:
Historical Price Targets Hiistorical Analyst Recommendations Earning Price Impact Analysis Seasonality Analysis
LLY is trading UP for the last 3 days, and it at trading at $799.86 with volume of 2,551,660 and a one day change of $12.64 (1.61%). Eli Lilly and Company has a 52-week low of 561.65 and a 52-week high of $972.53. The business's 50-day moving average price is $810.99 and its 200 day moving average price is $874.33. The firm has a market cap of $740 million, a P/E ratio of 112.43, and a beta of 0.43.
Venture capital firm Andreessen Horowitz said on Friday it was working with Eli Lilly to launch a $500 million venture fund that will be fully funded by the U.S. drugmaker. Employers are increasingly requiring workers on GLP-1 medications to enroll in nutrition and lifestyle coaching programs. Startup Virta Health saw 60% revenue growth last year, topping $100 million, driven by demand for its employer weight loss management program. MENLO PARK, Calif.--(BUSINESS WIRE)--Andreessen Horowitz (a16z) Bio + Health today announced a newly formed, first-of-its-kind venture capital fund to fuel broader innovation in human health, in partnership with Eli Lilly and Company (“Lilly”). The Biotech Ecosystem Venture Fund (“Fund”) seeks to drive transformative progress in healthcare by investing in therapeutic platforms and cutting-edge technology companies that can bring new medicines and disease treatments to improve patients' lives. M.
For more information on LLY:
Historical Price Targets Hiistorical Analyst Recommendations Earning Price Impact Analysis Seasonality Analysis
GILD is trading UP for the last 1 days, and it at trading at $89.93 with volume of 5,789,701 and a one day change of $0.79 (0.89%). Gilead Sciences, Inc. has a 52-week low of 62.07 and a 52-week high of $98.90. The business's 50-day moving average price is $90.39 and its 200 day moving average price is $78.62. The firm has a market cap of $115 million, a P/E ratio of 183.22, and a beta of 0.19.
For more information on GILD:
Historical Price Targets Hiistorical Analyst Recommendations Earning Price Impact Analysis Seasonality Analysis
A is trading UP for the last 1 days, and it at trading at $137.58 with volume of 1,054,009 and a one day change of $0.58 (0.42%). Agilent Technologies, Inc. has a 52-week low of 124.87 and a 52-week high of $154.82. The business's 50-day moving average price is $137.01 and its 200 day moving average price is $138.59. The firm has a market cap of $38 million, a P/E ratio of 35.83, and a beta of 1.07.
For more information on A:
Historical Price Targets Hiistorical Analyst Recommendations Earning Price Impact Analysis Seasonality Analysis
Top gainers in Biotechnology and Gene Therapy - WAT, LLY, GILD, A
By KlickAnalytics Data Insights | January 10, 2025 04:38PM ET
Following are the Top 5 companies based on their one-day percentage change within the 'Biotechnology and Gene Therapy' theme.
Waters Corporation (WAT)
WAT is trading UP for the last 1 days, and it at trading at $380.97 with volume of 474,570 and a one day change of $6.77 (1.81%). Waters Corporation has a 52-week low of 279.31 and a 52-week high of $397.02. The business's 50-day moving average price is $364.31 and its 200 day moving average price is $332.96. The firm has a market cap of $22 million, a P/E ratio of 38.99, and a beta of 0.97.
Top news headlines for WAT
For more information on WAT:
Eli Lilly and Company (LLY)
LLY is trading UP for the last 3 days, and it at trading at $799.86 with volume of 2,551,660 and a one day change of $12.64 (1.61%). Eli Lilly and Company has a 52-week low of 561.65 and a 52-week high of $972.53. The business's 50-day moving average price is $810.99 and its 200 day moving average price is $874.33. The firm has a market cap of $740 million, a P/E ratio of 112.43, and a beta of 0.43.
Top news headlines for LLY
For more information on LLY:
Gilead Sciences, Inc. (GILD)
GILD is trading UP for the last 1 days, and it at trading at $89.93 with volume of 5,789,701 and a one day change of $0.79 (0.89%). Gilead Sciences, Inc. has a 52-week low of 62.07 and a 52-week high of $98.90. The business's 50-day moving average price is $90.39 and its 200 day moving average price is $78.62. The firm has a market cap of $115 million, a P/E ratio of 183.22, and a beta of 0.19.
For more information on GILD:
Agilent Technologies, Inc. (A)
A is trading UP for the last 1 days, and it at trading at $137.58 with volume of 1,054,009 and a one day change of $0.58 (0.42%). Agilent Technologies, Inc. has a 52-week low of 124.87 and a 52-week high of $154.82. The business's 50-day moving average price is $137.01 and its 200 day moving average price is $138.59. The firm has a market cap of $38 million, a P/E ratio of 35.83, and a beta of 1.07.
For more information on A:
This article was generated by KlickAnalytics data insight content engine.
Disclaimer: the above is a summary showing certain market information. KlickAnalytics is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from various resources and more. Communications displaying market prices, data and other information available in this post are meant for purely for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.